Lite Strategy, Inc. Cash Flow Conversion Efficiency
Lite Strategy, Inc. cash flow conversion efficiency. Based on the latest financial reports, Lite Strategy, Inc. (LITS) has a cash flow conversion efficiency ratio of -0.040x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-4.51 Million) by net assets ($112.27 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Lite Strategy, Inc. (2021–2025)
Cash flow conversion efficiency of Lite Strategy, Inc. from 2021 to 2025. This chart illustrates how Lite Strategy, Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View Lite Strategy, Inc. stock quote for real-time trading data and today's change.
Lite Strategy, Inc. Cash Flow Conversion Ratio Explained
Lite Strategy, Inc. cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Lite Strategy, Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Lite Strategy, Inc. ranked by their cash flow conversion efficiency. Also see market cap of Lite Strategy, Inc. for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Meditera Tibbi Malzeme Sanayi ve Ticaret AS
IS:MEDTR
|
0.057x |
|
Pembangunan Jaya Ancol Tbk
JK:PJAA
|
-0.005x |
|
OCA Acquisition Corp
NASDAQ:OCAX
|
-0.003x |
|
CANEX Metals Inc
V:CANX
|
0.005x |
|
Touax SCA
PA:TOUP
|
0.021x |
|
Global SM Tech Limited
KQ:900070
|
0.009x |
|
Aspocomp Group Oyj
HE:ACG1V
|
0.034x |
|
Tower Real Estate Investment Trust
KLSE:5111
|
0.025x |
Annual Cash Flow Conversion Efficiency for Lite Strategy, Inc. (2021–2025)
The table below shows the annual cash flow conversion efficiency of Lite Strategy, Inc. from 2021 to 2025. Review how financially flexible is Lite Strategy, Inc. to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | $16.93 Million | $-20.84 Million | -1.231x | +19.46% |
| 2024-06-30 | $33.02 Million | $-50.47 Million | -1.529x | +28.28% |
| 2023-06-30 | $24.62 Million | $-52.48 Million | -2.131x | -129.18% |
| 2022-06-30 | $52.41 Million | $-48.75 Million | -0.930x | -43.93% |
| 2021-06-30 | $49.47 Million | $-31.96 Million | -0.646x | -- |
About Lite Strategy, Inc.
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.